Chromosome studies in polycythemia vera.
Polycythemia vera (PV) represents an apparent monoclonal stem cell proliferation with a frequent transition to full neoplastic behavior. Up to 26% of untreated PV patients can be expected to have some chromosome abnormalities in the marrow at the time of diagnosis, and 10--15% have an abnormal cell line or clone. Both structural and numerical aberrations occur. Aneuploidy is the most common type of chromosome abnormality, however, with hyperdiploid clones occurring more frequently than hypodiploid clones. Chromosomes 1, 8, 9 and 20 are involved in a non-random pattern, and aberrations of all the F group, or at least the No. 20 chromosome seem to be associated to some extent with diseases involving erythroid hyperplasia. Leukemia develops in a certain percentage of patients regardless of the type of treatment they have received, but the relationship, if any, between the chromosome abnormalities and the development of leukemia is still uncertain. The abnormal clones that occur in PV appear to be quite stable and there is no indication at this time that they correlate with a prognosis of leukemic transformation.
D000782:Aneuploidy; D001853:Bone Marrow / Q000473:pathology; D002460:Cell Line; D002869:Chromosome Aberrations / Q000150:complications*; D025063:Chromosome Disorders; D002999:Clone Cells; D006801:Humans; D007938:Leukemia / Q000150:complications; D011087:Polycythemia Vera / Q000150:complications / Q000473:pathology*